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RESEARCH ARTICLE Open Access
The effect of crystalloid versus medium molecular
weight colloid solution on post-operative nausea
and vomiting after ambulatory gynecological
surgery - a prospective randomized trial
Ivan Hayes1, Raza Rathore1, Kingsley Enohumah1, Edgar Mocanu2, Deepak Kumar1 and Conan McCaul1,3,4*
Abstract
Background: Intravenous fluid is recommended in international guidelines to improve patient post-operative
symptoms, particularly nausea and vomiting. The optimum fluid regimen has not been established. This
prospective, randomized, blinded study was designed to determine if administration of equivolumes of a colloid
(hydroxyethyl starch 130/0.4) reduced post operative nausea and vomiting in healthy volunteers undergoing
ambulatory gynecologic laparoscopy surgery compared to a crystalloid solution (Hartmann’s Solution).
Methods: 120 patients were randomized to receive intravenous colloid (N = 60) or crystalloid (N = 60)
intra-operatively. The volume of fluid administered was calculated at 1.5 ml.kg-1 per hour of fasting. Patients were
interviewed to assess nausea, vomiting, anti-emetic use, dizziness, sore throat, headache and subjective general
well being at 30 minutes and 2, 24 and 48 hours post operatively. Pulmonary function testing was performed on a
subgroup.
Results: At 2 hours the proportion of patients experiencing nausea (38.2 % vs 17.9%, P = 0.03) and the mean
nausea score were increased in the colloid compared to crystalloid group respectively (1.49 ± 0.3 vs 0.68 ± 0.2,
P = 0.028). The incidence of vomiting and anti-emetic usage was low and did not differ between the groups.
Sore throat, dizziness, headache and general well being were not different between the groups. A comparable
reduction on post-operative FVC and FEV-1 and PEFR was observed in both groups.
Conclusions: Intra-operative administration of colloid increased the incidence of early postoperative nausea and
has no advantage over crystalloid for symptom control after gynaecological laparoscopic surgery.
Keywords: Fluid therapy, Colloid, Crystalloid solutions, Nausea, Vomiting
Background
The incidence of post operative nausea and vomiting
(PONV) following ambulatory surgery is 40%–60% and
ambulatory gynecological patients are at particularly high
risk. PONV continues to occur despite pharmacological
prophylaxis in high risk groups. [1-6] PONV has the po-
tential to cause delays in meeting discharge criteria both
from the recovery room to ward and from the day ward to
home. [7-9] PONV causes patient discomfort and can re-
sult in unanticipated overnight hospital admission which
leads to increased economic costs. PONV control is a
strong patient priority and there is a strong association be-
tween PONV and patient dissatisfaction with their
anesthesia care. [10-12] The routine use of anti-emetics
remains controversial as their efficacy is limited in patients
with low risk profiles. [13] In these circumstances,
pharmacologic prophylaxis increases the risk of adverse
drug effects for the patient in addition to increasing over-
all costs of care [13].
‘Rehydration’ is a recommended strategy to reduce
PONV but have been subject to a relatively small number
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of studies in ambulatory anesthesia and there is no con-
sensus as to which fluid or volume is optimal. [14-18]
Studies suggest that intravenous crystalloid administra-
tion in healthy patients reduces the incidence of nausea,
vomiting and antiemetic use after gynecological laparos-
copy and other ambulatory procedures. [19-22] The anti-
emetic efficacy of intravenous crystalloid appears to be
dose related. Lower volumes do not have a significant ef-
fect and large volumes (30–40 ml/kg) are necessary to es-
tablish benefit. [19,23,24] Intravenous crystalloid has a
short intravascular half life, its expected duration of ac-
tion is short and solutions with longer durations of ac-
tion e.g. colloid would be anticipated to have greater
benefit. [25] We chose to study the effect of intravenous
colloid solution in PONV and hypothesized that intra-
venous colloid would have a greater reduction on PONV
than an equivalent volume of crystalloid solution.
Methods
Following approval by the Institutional Research Ethics
committee (Rotunda Hospital, Dublin, Ireland), ASA I-II
female patients, aged 18–45 years who were scheduled
to undergo elective gynecological laparoscopy were
invited to participate in the study. The study took place
in the operating theatres, recovery room and day ward
of the Rotunda Hospital, a tertiary level university teach-
ing hospital. Exclusion criteria included age <18 or
>45 years, cardio-respiratory disease, excessive intra-
operative blood loss, BMI >30 and relevant drug allergy
to medication used in the protocol. Informed written
consent was obtained from all patients. Patients were
randomized using a table of computer generated num-
bers each of which was linked to a sealed envelope that
contained the allocation to one of two groups. The crys-
talloid group (CRL) received Compound Sodium Lactate
at a volume of 1.5 ml.kg-1.hr-1 of fasting time adminis-
tered as an intra-operative bolus. Compound Sodium
Lactate (Baxter Health Care, Thetford, UK) contains so-
dium 131 mmol litre−1, potassium 5 mmol litre−1, cal-
cium 2 mmol litre−1, chloride 111 mmol litre−1 and
lactate 29 mmol litre−1. The colloid (CLD) group
received 6% Hydroxy Ethyl Starch 130/0.4 in 0.9% saline
(VoluvenW; Fresenius Kabi, Bad Homburg, Germany) at
a volume of 1.5 ml.kg-1.hr-1 of fasting time as an intra-
operative bolus. To ensure blinding of both the patient
and the investigator, all fluid administration was initiated
after induction of anesthesia and completed prior to
transfer to PACU. No further fluid was administered
after this time. Neither the patient nor the investigator
was aware of group assignment.
All patients received general anesthesia. Intravenous
access was obtained after local anesthetic infiltration of
the skin. Anesthesia was induced with fentanyl 1.5 mcg.
kg-1, Propofol 2–3 mg.kg-1 and Atracurium 0.35 mg.kg-1
to facilitate airway control. The lungs were ventilated
via a supraglottic airway (LMA SupremeTM size 4) with
Table 1 Patient characteristics
Crystalloid Colloid P value
Age (yr) 35.1 (4.3) 35.6 (5.3) 0.55
Female (%) 100 100 1.0
Weight (kg) 63.7 (59.0–72.0) 64.0 (54.7–70.0) 0.61
BMI (kg.m2) 23.7 (21.6–25.4) 22.9 ( 20.9–25.1) 0.34
Duration of Fast (Hr) 13.0 ( 11.0–17.0) 14.0 (12.0–15.7) 0.38
PONV Risk Factors (N)
1 22 21 0.94
2 32 30 0.93
3 1 3 0.6
4 0 0 1.0
Procedure
Laparoscopy – Diagnostic (N) 39 38 0.88
Laparoscopy – Proceed (N) 17 17 0.88
Estimated Fluid Deficit (L) 1.37 (0.34) 1.36 (0.38) 0.88
Volume of Fluid Received (ml/kg) 21.0 (4.7) 21.6 (5.5) 0.58
Duration of Anesthesia (min) 40.0 (30.0–50.0) 40.0 (30.0–45.0) 0.14
Hypotensive Episodes requiring Treatment (N) 11 8 0.62
Intraperitoneal CO2 (L) 9.1 (7.0–15.6) 10.5 (8.1–17.5) 0.33
Propofol ( mg.kg-1) 2.6 (2.4–3.0) 2.6 (2.4–2.9) 0.7
Atracurium (mg.kg-1) 0.37 (0.34–0.43) 0.37 ( 0.35–0.41) 0.9
Continuous data are presented as mean, standard deviation and median, interquartile range. Categorical data are presented as Number and percentage.
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tidal volume (Vt) 4–6 ml.kg-1, maximum airway pres-
sure (P max) 30 cm H2O and a positive end expiratory
pressure (PEEP) of 5 cm H2O. The respiratory rate was
adjusted to maintain isocapnia. Anaesthesia was maintained
with 1 MAC of Sevoflurane in a mixture of O2 and air to
achieve a FiO2 of 0.5. Muscle relaxation was antagonized
with neostigmine 2.5 mg and glycopyrrolate 0.5 mg at the
end of surgery. Before discontinuation of anesthesia, each
patient received rectal Diclofenac 100 mg and Paracetamol
1000 mg i.v. Prophylactic anti-emetics were not administered.
Postoperative care was standardized. In PACU, patients
reporting pain were given 25 mcg of Fentanyl i.v. as
required to achieve a pain score of 4 or less. On the ward
Pethidine 50 mg intramuscularly or simple oral analge-
sics (Paracetamol/Codeine 500-1000 mg/8-16 mg were
administered on a 3 and 6 hourly PRN basis as required
respectively. Rescue anti-emetics were available in the
form of ondansetron 4 mg i.v. in PACU and cyclizine
50 mg on the ward every 8 hours on a demand basis. In
the event of failure of cyclizine, prochlorperazine
12.5 mg IM was available 8 hourly. Patients were pre-
scribed oral Paracetamol/Codeine 500–1000 mg/8–
16 mg every 6 hours and Diclofenac 50 mg every 8 hours
to take at home if required.
The primary endpoint was the presence of nausea at 2
hours post-operatively. Nausea was assessed using a
standard verbal rating scale (VRS 0=no nausea, 10=
worst imaginable). [20] Secondary endpoints included
vomiting, rescue antiemetic use, dizziness, sore throat and
headache. Dry retching was considered to be vomiting for
the purposes of the study. Symptoms were recorded as
present or absent at each time point i.e. cumulative data
were not reported. Anti-emetics were offered by PACU
nursing staff to patients if they reported nausea when clin-
ically assessed using a modified Aldrete score. [26] Pre
and post-operative pulmonary function tests were per-
formed in a subset of 30 patients following consultation
with the institutional ethics committee after development
of post-operative pulmonary edema in a study patient. Pul-
monary function was assessed at the bedside using Viasys
Microlab Spirometer (Viasys Healthcare, Warwick, United
Kingdom) Patients were assessed by a single data collector
(RR) at 30 mins, 2 hours, 24 hours and 48 hours post-
operatively. The 24 and 48 hour assessments were carried
out by telephone interview.
Statistics were performed using Sigma Stat, (Jandel
Scientific). Categorical data were analyzed using the χ 2
test or the Fisher's exact test as appropriate. Continuous
data were analyzed with the Student-t test or repeated
measures analysis of variance as appropriate. Normally
distributed data are presented as means and standard
deviation and data that was not normally distributed is
presented as medians and interquartile range. Categor-
ical data is presented as proportions and percentages.
Sample size was calculated as follows: To detect a clinic-
ally significant difference of 25% reduction in mean nausea
scores based on a baseline score of 40 mm, we calculated
a sample size of 60 patients per group (a = 0.05, β= 0.2).
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Results
There were no baseline differences between the groups
in terms of age, weight, BMI, risk factors for PONV, fast-
ing duration or anaesthetic technique (Table 1).
At 2 hours the proportion of the patients experiencing
nausea (38.2 vs 17.9%, P= 0.03) (Figure 2, Panel A) and
the mean nausea score (1.49 ± 0.3 vs 0.68± 0.2, P = 0.028)
(Figure 2, Panel B) and were increased in the colloid
group compared to crystalloid respectively. There was
no difference between the groups in these outcomes at
any other time. The incidence of vomiting (Figure 1,
Panel C) and anti-emetic usage (Table 2) was low and
did not differ between the groups. Post-operative anal-
gesic use was not different between the groups. (Table 2)
Sore throat, dizziness, headache and general well being
were not different between the groups post-operatively
(Figure 3 Panels A-C). A comparable reduction on
post-operative FVC and FEV-1 and PEFR was
observed in both groups (Figure 4 Panels A-C).
One patient was withdrawn from the colloid group
after developing high airway pressures in the operating
room. In PACU a chest x-ray showed pulmonary edema
which was treated with diuretics and oxygen. She was
well at follow up.
Discussion
Multiple previous prospective randomized clinical trials
have demonstrated a reduction in post-operative nausea
and vomiting associated with intravenous crystalloid
administration which is dose related. [19-22,24,27,28]
Assessed for eligibility (n= 125)  
)
Excluded  (n= 5) 
Not meeting inclusion criteria (n= 2) 
Declined to participate (n=3) 
Other reasons (n= 0) 
Analysed  (n= 56) 
Excluded from analysis (reasons – fluid error 
1, uncontactable 2, discontinued intervention 
1) (n= 4 )
Lost to follow-up (reasons – not contactable for 
interview) (n= 2) 
Discontinued intervention  (n= 1) 
Allocated to intervention (n=  60) 
Received allocated intervention (n=  59)
Did not receive allocated intervention (reason 
- error) (n= 1 )
Lost to follow-up (reason – not contactable for 
interview) (n= 3) 
Discontinued intervention (n= 0) 
Allocated to intervention (n= 60) 
Received allocated intervention (n= 60)
Did not receive allocated intervention (give 
reason - error) (n=2  )
Analysed  (n= 55) 
Excluded from analysis (reasons – fluid error 
2, uncontactable 3) (n= 5 )
Allocation
Analysis
Follow-Up
Randomized (n= 120) 
Enrollment
Figure 2 Consort flow diagram.
Table 2 Post-operative medication
Opioids Crystalloid Colloid P value
Fentanyl (mcg) 25 (0.0–100) 25 (0.0–75.0) 0.52
Pethidine (mg) 10.3 (23.7) 4.9 (16.2) 0.17
Rescue Anti-emetics
Number of Patients Requiring Rescue
Anti-emetics N(%) 9 (16.9) 5 (5.3) 0.37
Time of Anti-emetic administration. N (%)
0–30 min 2 (3.6) 3 (5.3) 0.98
30 min–2 hrs 5 (9.1) 2 (3.5) 0.42
2–24 hrs 3 (5.7) 0 (0.0) 0.22
Continuous data are presented as mean, standard deviation and median,
interquartile range. Categorical data are presented as Number and percentage.
Note – One patient required anti-emetic more than one occasion.
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Intravenous fluid administration has also been shown to
improve multiple other common post-operative symp-
toms and to shorten time to achieving discharge criteria.
[21,23] Recent consensus guidelines by the ASA and
ASPAN recommend peri-operative rehydration to
reduce baseline risk of PONV but no specific fluid for-
mulation or volume or rate of administration have been
advocated. [16,17] The present study aimed to determine
whether a colloidal solution may have any advantage
over crystalloid in magnitude or duration of effect on
PONV. We did not confirm any such benefit and in fact
demonstrated an increase in early nausea in patients re-
ceiving the colloid solution. The observed nausea was
mild and did not affect general well being. Secondary
outcomes – the incidence of headache, sore throat and
dizziness were not improved by colloid administration.
There have been a small number of related studies in
diverse patient populations to date and none in ambula-
tory care specifically. The results of these studies have
been conflicting. Haentjens, in a prospective randomised
trial investigated the effect of hydroxyethyl starch 130/
0.4 or saline in a mixed surgical population undergoing
non-ambulatory surgery and showed no difference be-
tween the groups in nausea and vomiting. [29] The
volumes of experimental fluids were similar to those
used in our study but were administered over a 24 hour
period whereas in our study they were administered
intra-operatively – a considerably shorter time period of
greater relevance to the ambulatory surgical population.
Moretti investigated the effect of 6% hetastarch in either
balanced salt (HS-NS) or lactated Ringer’s solution (HS-
BS) with lactated Ringer’s in an older population under-
going major intracavity surgery. [30] Fluid administration
was algorithmically determined and PONV was more
common in patients receiving Ringer’s lactate and clinical
evidence suggested that significant interstitial oedema
developed in this group. The authors speculated that the
reduction in PONV in the colloid group was due to less
bowel edema. It is perhaps unsurprising that tissue
edema occurred in the crystalloid group as these patients
received a mean volume of 5946 ml compared to
1301 ml and 1448 ml in the HS-NS and HS-BS groups
respectively. In a study of healthy non-anaesthetised
volunteers, subjects receiving 50 ml/kg of sodium chlor-
ide reported abdominal discomfort more frequently than
those who received an equivalent volume of lactated
Ringer’s solution, indicating a possible difference in the
tendency to cause bowel edema between these solutions.
[31] Wilkes studied 6% hetastarch in either Hartmann’s
solution or 0.9% Sodium Chloride in elderly patients
undergoing open surgery and showed improved gastric
perfusion and a trend toward less vomiting in the former
group, suggesting that the electrolyte composition of the
colloidal solution has some influence on its emetogenic
potential. [32] In a study of female patients undergoing
elective laparoscopic cholecystectomy, Chaudhary did
not demonstrate any differences on PONV between
groups receiving 12 ml.kg-1 of Ringers lactate or 12 ml.
kg-1 4.5% Hydroxyethyl starch prior to induction of
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anaesthesia. This study was notable for an extremely high
incidence of PONV. [33] The colloid intervention group
also received a subsequent infusion of Ringers lactate
and final fluid volumes were not reported. In a study of
patients undergoing cholecystectomy, Turkistani admi-
nistered 10 ml.kg-1 of one of three colloidal study solu-
tions of low, medium and high molecular weight
respectively. [34] The study was underpowered to detect
a difference between colloid groups but showed a distinct
trend towards greater PONV with increasing molecular
weight.
In the studies which have been carried out to date on
the effects of intravenous fluids on PONV after gynaeco-
logical laparoscopy, the specific mechanism of action of
fluid has not been determined. Intravenous fluids have
not been found to be beneficial in thyroidectomy and
therapeutic abortion suggesting that the effect may be
specific to laparoscopic surgery. [35,36] Speculative
mechanisms of PONV after laparoscopy include a reduc-
tion in gut mucosal blood flow that is known to occur
during pneumoperitoneum and anaesthesia. [37] Mesen-
teric hypoperfusion in turn may lead to release of 5-
hydroxytryptamine which is a potent trigger of nausea
and vomiting. High volume intravenous fluids have also
been shown to reduce post-operative pain and could po-
tentially reduce opioid consumption, both of which can
be emetogenic. We chose to study hydroxyethyl starch
130/0.4 which is a medium molecular weight starch in a
balanced electrolyte solution designed to minimize tissue
accumulation and coagulation dysfunction while retain-
ing the hemodynamic efficacy of conventional starches.
[38] We anticipated that the colloidal study solution
would have a more marked and sustained effect than
crystalloid on restoration of intravascular volume and
consequently reduce intestinal mucosal ischemia and
subsequent PONV. [39] The findings of the study were
opposite to that expected and a greater proportion of
the patients who received colloid were nauseated. We
speculate that this observation is explicable by a relative
increase in blood viscosity that has been previously
reported with hydroxyethyl starches that may paradoxic-
ally impair microcirculatory perfusion. The observation
that highest incidence of nausea occurred at 2 hours
post-operatively in both groups and occurred more com-
monly in patients who had received intravenous fentanyl
in PACU, suggests that the mechanism of nausea in this
study population was at least in part opioid induced,
which is not known to be ameliorated by intravenous
fluid administration.
Our study has a number of limitations. First, there was
no untreated control group and a single dose of colloid
was evaluated, therefore beneficial effects of the solution
at different doses cannot be excluded. Second, blinding is
incomplete as the anaesthetist who administered the
FV
C 
(L
itr
e)
0
1
2
3
4
5 Crystalloid
Colloid
  *
    *
Baseline Post-Op
A. FVC
B. FEV 1
C. PEFR 
PE
F 
(L
 / m
in
) 
0
100
200
300
400
500
600 Crystalloid
Collo id
Baseline Post-Op
**
FE
V 
1 
(L
itr
e)
0
1
2
3
4
5
Crystalloid 
Colloid 
Baseline Post-Op
Figure 4 Panel A: Data are non parametric and presented as
mean and standard error of the mean. * Indicates P< 0.05 for
post operative crystalloid and colloid vs. baseline (P=0.013, 0.016
respectively). Panel B: Data are non parametric and presented as
mean and standard error of the mean. * Indicates P< 0.05 for post
operative crystalloid and colloid vs. baseline (P=0.025, 0.012
respectively). Panel C: Data are non parametric and presented as
mean and standard error of the mean. * Indicates P< 0.05 for post
operative crystalloid and colloid vs. baseline (P=0.001, 0.004
respectively).
Hayes et al. BMC Anesthesiology 2012, 12:15 Page 6 of 8
http://www.biomedcentral.com/1471-2253/12/15
fluids was not blinded. Third, the study was conducted
in patients without cardiorespiratory disease and use of
such volumes of rapidly administered intravenous fluids
cannot be recommended to all patients. Fourth, the
study was underpowered to demonstrate statistical dif-
ferences for secondary outcomes, particularly pulmonary
function which showed clear trends towards greater im-
pairment in the colloid group. Fifth, following discharge
from PACU oral intake was not restricted or measured.
Last, prophylactic anti-emetics were not administered,
limiting the ability of clinicians to extrapolate of our
findings to patients who receive such interventions.
Conclusion
In conclusion, we were unable to demonstrate a benefit of
colloid over crystalloid in PONV after ambulatory gyne-
cologic surgery and cannot recommend it at the investi-
gated dose for this purpose.
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